- Home
- ICMB vs PLUR Comparison
ICMB vs PLUR Comparison
Compare ICMB & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICMB
- PLUR
- Stock Information
- Founded
- ICMB 2012
- PLUR 2001
- Country
- ICMB United States
- PLUR Israel
- Employees
- ICMB N/A
- PLUR N/A
- Industry
- ICMB Finance: Consumer Services
- PLUR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ICMB Finance
- PLUR Health Care
- Exchange
- ICMB Nasdaq
- PLUR Nasdaq
- Market Cap
- ICMB 41.1M
- PLUR 41.9M
- IPO Year
- ICMB N/A
- PLUR N/A
- Fundamental
- Price
- ICMB $2.75
- PLUR $4.83
- Analyst Decision
- ICMB
- PLUR Strong Buy
- Analyst Count
- ICMB 0
- PLUR 1
- Target Price
- ICMB N/A
- PLUR $12.00
- AVG Volume (30 Days)
- ICMB 25.0K
- PLUR 61.6K
- Earning Date
- ICMB 05-13-2025
- PLUR 05-13-2025
- Dividend Yield
- ICMB 17.27%
- PLUR N/A
- EPS Growth
- ICMB N/A
- PLUR N/A
- EPS
- ICMB 0.82
- PLUR N/A
- Revenue
- ICMB $20,996,189.00
- PLUR $1,034,000.00
- Revenue This Year
- ICMB N/A
- PLUR $472.39
- Revenue Next Year
- ICMB N/A
- PLUR $254.29
- P/E Ratio
- ICMB $3.37
- PLUR N/A
- Revenue Growth
- ICMB N/A
- PLUR 203.23
- 52 Week Low
- ICMB $2.46
- PLUR $3.33
- 52 Week High
- ICMB $3.47
- PLUR $7.13
- Technical
- Relative Strength Index (RSI)
- ICMB 45.17
- PLUR 53.05
- Support Level
- ICMB $2.75
- PLUR $4.61
- Resistance Level
- ICMB $2.95
- PLUR $5.40
- Average True Range (ATR)
- ICMB 0.11
- PLUR 0.52
- MACD
- ICMB -0.00
- PLUR 0.08
- Stochastic Oscillator
- ICMB 18.00
- PLUR 62.09
About ICMB Investcorp Credit Management BDC Inc.
Investcorp Credit Management BDC Inc is an externally managed, non-diversified closed-end management investment firm that has elected to be regulated as a business development company (BDC). Its investment objective is to maximize total return to stockholders in the form of current income and capital appreciation by investing in debt and related equity of privately held lower middle-market companies. The company principally invests in the debt of middle-market companies, which it defines as those companies that have an enterprise value.
About PLUR Pluri Inc.
Pluri Inc is a biotechnology company, that creates cell-based products for commercial use and is pioneering a biotech revolution that promotes wellbeing and sustainability. The company's technology platform developed a three-dimensional, or 3D, technology platform for cell expansion with an industrial scale in-house Good Manufacturing Practice, or GMP, cell manufacturing facility. It uses its technology in the field of regenerative medicine, food tech and agricultural technology or agtech.